Provided herein are methods of treating cancer in a subject including detecting an amount of PD-L1(+) natural killer (NK) cells in a biological sample from the subject and treating the subject with an anti cancer therapy. Provided herein are methods of treating cancer in a patient including ...
3. Durvalumab as third-line or latertreatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label,single-arm, phase 2 study 4. ALT-803, an IL-15 superagonist, incombination with nivolumab in patients with metastatic non-small cell lungcancer: a non-randomised, open-label, ph...
Combination therapy strategies for improving PD-1 blockadeefficacy: a new era in cancer immunotherapy.3. Landscape of combination therapy trials in breast cancer brainMetastasis.4. Combination immunotherapy: a road map.5. Combination of CTLA-4 and PD-1 blockers for treatment of cancer....
3.I-SPY2 Trial Consortium, Yee D, DeMichele AM, et al. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized ...
3.I-SPY2 Trial Consortium, Yee D, DeMichele AM, et al. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breas...
3. Ramalingam SS, CIuleanu TE, Pluzanski A, et al. Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1. J Clin Onc...
Novel PDL1 regulation mechanism provides opportunity for prostate cancer treatmentdoi:10.1038/s41585-020-0323-yTim ThomasNature Reviews Urology
[Key words]primary liver cancer;PD-1;PD-L1;immunohistochemistry 原发性肝癌是消化系统恶性肿瘤,其全球发病率及死亡率正逐年增长,与此同时,作为主要辅助治疗手段的化疗和放疗对大多数中晩期进展期肝癌的疗效不佳,患者预后较差。除去外科手术治疗及常规辅助放化疗,正在发展中的免疫治疗逐渐成为肝癌治疗的新策略 原发...
Immunology-based therapies are emerging as an effective cancer treatment, using the body's immune system to target tumors. Immune checkpoints, which regulate immune responses to prevent tissue damage and autoimmunity, are often exploited by cancer cells to avoid destruction. The discovery of checkpoint...
2 免疫检查点与PD-1/PD-L1抗体 ImmunecheckpointandPD-1/PD-L1antibody 3 PD-1/PD-L1抑制剂现状 CurrentstatusofPD-1/PD-L1inhibitors 4 问题与展望 ProblemsandProspects 肿瘤免疫治疗TumorImmunotherapy 肿肿瘤瘤免免疫疫疗疗法法的的分现类状 肿瘤免疫疗法的原理和分类PrinciplesandClassificationofTumorImmunotherapy...